Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
GAINESVILLE, FL, USA, February 18, 2021 /EINPresswire.com/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced two additions to …